Showing 1 to 10 of 33
| Title | Reference number | Reference number sort | Published | Published date sort | Last updated | Last updated sort |
|---|---|---|---|---|---|---|
| COVID-19 rapid guideline: children and young people who are immunocompromised | Reference number:NG174 | NG00174 | Published:01 May 2020 | 20200501 | Last updated:21 May 2020 | 20200521 |
| COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders | Reference number:NG167 | NG00167 | Published:03 April 2020 | 20200403 | Last updated:21 May 2020 | 20200521 |
| COVID-19 rapid guideline: dialysis service delivery | Reference number:NG160 | NG00160 | Published:20 March 2020 | 20200320 | Last updated:21 May 2020 | 20200521 |
| COVID-19 rapid guideline: chronic kidney disease | Reference number:NG176 | NG00176 | Published:15 May 2020 | 20200515 | Last updated:15 May 2020 | 20200515 |
| COVID-19 rapid guideline: interstitial lung disease | Reference number:NG177 | NG00177 | Published:15 May 2020 | 20200515 | Last updated:15 May 2020 | 20200515 |
| COVID-19 rapid guideline: acute kidney injury in hospital | Reference number:NG175 | NG00175 | Published:06 May 2020 | 20200506 | Last updated:06 May 2020 | 20200506 |
| COVID-19 rapid guideline: antibiotics for pneumonia in adults in hospital | Reference number:NG173 | NG00173 | Published:01 May 2020 | 20200501 | Last updated:01 May 2020 | 20200501 |
| COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response | Reference number:NG169 | NG00169 | Published:09 April 2020 | 20200409 | Last updated:30 April 2020 | 20200430 |
| COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community | Reference number:NG163 | NG00163 | Published:03 April 2020 | 20200403 | Last updated:30 April 2020 | 20200430 |
| COVID-19 rapid guideline: critical care in adults | Reference number:NG159 | NG00159 | Published:20 March 2020 | 20200320 | Last updated:29 April 2020 | 20200429 |